The University of Texas Health Science Center at Tyler

Closed portfolio with a later-stage archive tilt

According to ClinicalTrials.gov-derived indexes, The University of Texas Health Science Center at Tyler sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).

7 total trials none currently recruiting 7 completed later-stage tilt upper quartile by trial count

The University of Texas Health Science Center at Tyler: 7 sponsored US clinical trials, none currently recruiting.

The University of Texas Health Science Center at Tyler sponsors 7 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 7 completed. 5 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Mycobacterium Avium Complex Lung Disease, with 1 trials.

Upper-quartile sponsor footprint

The University of Texas Health Science Center at Tyler sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

7 total, page 1 of 1

COMPLETED NA

Randomized Trial of Physical Activity Self-Management Intervention for Patients With COPD

NCT01108991
COMPLETED Phase 2

Tigecycline for Treatment of Rapidly Growing Mycobacteria

NCT00600600
COMPLETED Phase 4

Use of Clarithromycin and Rifabutin for the Treatment of M. Avium Complex (MAC) Lung Disease

NCT00598897
COMPLETED Phase 4

Use of Azithromycin and Rifabutin Administered 3 Times Weekly for the Treatment of M. Avium Complex (MAC) Lung Disease

NCT00598962
COMPLETED Phase 4

Azithromycin in the Treatment of M. Avium Complex Lung Disease

NCT00599079
COMPLETED Phase 4

Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobacteria (NTM)

NCT00600769
COMPLETED Phase 3

Effectiveness of Rifabutin in the Treatment of Mycobacterium Avium Complex

NCT03164291

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 3 1
Phase 4 4

Therapeutic Areas

Mycobacterium Avium Complex Lung Disease 1
Mycobacterium Avium Complex 1
Nontuberculous Mycobacteria 1

How the The University of Texas Health Science Center at Tyler archive is shaped

7 indexed studies, none listed as recruiting (0% open); 7 completed (100%).

Phase mix: 5 late (III/IV) vs 1 early (I/II) (later-stage heavy).

Top condition: Mycobacterium Avium Complex Lung Disease (1 trial), 2 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

The University of Texas Health Science Center at Tyler: archived-pipeline peers nationwide

Peers matched on 7 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

The University of Texas Health Science Center at Tyler sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40% Total trials Recruiting share The University of Texas Health Science Center at Tyler3M4Life Research89bioAbbott Diagnostics Division10xBio22nd Century Group23andMe3-C Institute for Social Development
The University of Texas Health Science Center at Tyler sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

The University of Texas Health Science Center at Tyler sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 7 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this The University of Texas Health Science Center at Tyler page

7 registered trials is a research-attention snapshot, not an endorsement of The University of Texas Health Science Center at Tyler or any single study.

  • None of The University of Texas Health Science Center at Tyler's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Mycobacterium Avium Complex Lung Disease is the condition The University of Texas Health Science Center at Tyler studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Mycobacterium Avium Complex Lung Disease trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. The University of Texas Health Science Center at Tyler pipeline card: 7 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.